Unruly Capital
unrulycap.comVCMatch tracks Unruly Capital as an investor focused on AI/ML, Biotech, and Medtech companies, Pre-Seed and Seed rounds, United States, United Kingdom, and Switzerland markets, and $268k to $45m check sizes. Upload your deck to compare your startup against the full private matching profile.
Check Size
$268k to $45m
Geography
United States, United Kingdom, and Switzerland
Investment Thesis
Unruly Capital operates as an early-stage, sector-agnostic (but deep-tech–heavy) investor that prioritizes transparency and founder-first signal clarity over marketing spin. They deploy relatively small checks at scale (Fund I: average check ~$267k across 73 investments) into health, bio, climate, manufacturing, energy, computing and transportation startups globally, using data to inform founder fit and their own accountability.
Is Unruly Capital right for your startup?
Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.
Investment Focus
Who should take a closer look
Unruly Capital is most relevant for founders raising Pre-Seed and Seed rounds in AI/ML, Biotech, Medtech, and Digital Health, especially across United States, United Kingdom, and Switzerland, with public check-size signals around $268k to $45m.
Focus statement
Early-stage (pre-seed/seed/angel) investments across deep technology areas — Health/Bio, Climate/Energy, Manufacturing, Computing, Transportation and Space — typically with ~ $267k average checks and international deal flow (US, UK, Europe, Africa). They emphasize portfolio breadth (high deal count) and deliberate, transparent deployment (Fund I metrics publicly disclosed).
Value Add
- Public, fully transparent internal dashboard: they publish deal-level and fund-level metrics (amount deployed, deals per quarter, check sizes, valuations, ownership, closing dates, follow-on reserves, write-offs, etc.) that most firms keep confidential.
- Open-source mindset: they plan to make their website open source and personally help other firms replicate the transparency tooling.
- High-volume, smaller-check approach within a traditional VC fund structure (Fund I: 73 investments, average check ~$267k, follow-on reserves 5%), enabling broad exposure across hard tech and climate/bio domains.
- Explicit founder-focused signalling: by making deployment capacity and historical behaviour public they reduce ambiguity founders face when selecting investors.
Stage And Sector Fit
Portfolio Highlights
Vertility Health
Biohealth
Multiple stealth portfolio companies
Various
Ready to find your perfect investor match?
Get Started Free